Zhengdan shares (300641) announced on the evening of May 6 that the company's shares and convertible bonds have serious abnormal fluctuations and will be suspended for verification.
According to the announcement, the deviation of the daily closing price increase of Zhengdan shares for 10 consecutive trading days (April 18, 2024 to May 6, 2024) reached 117.60%, and the deviation of the closing price of Zhengdan convertible bond transactions reached 117.36% during the same period. According to the relevant provisions of the "Shenzhen Stock Exchange Trading Rules", it is a situation of serious abnormal fluctuations in the trading of stocks and convertible bonds.
Zhengdan shares said that the company's shares and convertible bonds have fluctuated greatly in recent trading prices, and in order to safeguard the interests of investors, the company will suspend trading for verification of the recent abnormal fluctuations in stock and convertible bond transactions. Upon application, the company's shares and convertible bonds will be suspended from the market open on May 7, 2024, and will resume trading after the company completes the relevant verification work and discloses the verification results.
In the 21 trading days from April 1 to May 6, the share price of Zhengdan shares rose from 4.32 yuan / share to 23.88 yuan / share, during which the increase was as high as 454.06%.
It is worth noting that in the recent abnormal market of Zhengdan shares, small and medium-sized investors with low risk tolerance have become the main group of buying operations.
According to the detailed table of serious abnormal fluctuations disclosed by the Shenzhen Stock Exchange today, from April 18 to May 6 (during the period of serious abnormality), among the 9.226 billion yuan of Zhengdan shares, small and medium-sized investors bought 6.18 billion yuan, accounting for 67% of the transaction. At the same time, small and medium-sized investors are the only net buying group among various market groups, with a net purchase amount of 405 million yuan. According to the account classification standards of the China Securities Regulatory Commission, natural person accounts with a market value of less than 3 million yuan are small and medium-sized investors.
Institutional seats and other natural persons with a market value of more than 3 million yuan shall be net sellers. Among them, the net sale of institutional seats was 340 million yuan, and the net sale of other natural persons was 65 million yuan. On the whole, small and medium-sized investors and other natural person groups have implemented nearly 96% of the buying operations during the serious abnormality of Zhengdan shares.
From April 29 to 30, the Shenzhen Stock Exchange has announced that it will focus on monitoring abnormal securities such as "Zhengdan shares".
Zhengdan Co., Ltd. is a high-tech enterprise in the field of special fine chemicals, mainly engaged in the research and development, production and sales of new environmental protection materials and special fine chemicals. The main business involves the fine chemical industry and the environmental protection new material industry, and the main products include trimellitic anhydride (TMA), trioctyl trimellinate (TOTM), vinyl toluene (VT), tetraxylene, etc.
According to the first quarter report of this year, Zhengdan Co., Ltd. achieved revenue of 518 million yuan in the first quarter, a year-on-year increase of 28.8%, and a net profit of 58.9925 million yuan, a year-on-year increase of 412.94%. Zhengdan said that the company's TMA production and sales increased in the first quarter of this year.
In 2023, Zhengdan Co., Ltd. will achieve operating income of 1.538 billion yuan, a year-on-year decrease of 20.09%, and net profit attributable to the parent company of 9.8751 million yuan, a year-on-year decrease of 82.31%.
As for the reasons for the decline in annual performance, Zhengdan Co., Ltd. pointed out in the annual report that in 2023, the evolution of the century-old changes will accelerate, the global economic recovery will be weak, the reconstruction of the industrial chain and supply chain will be accelerated, the game between major powers and regional turmoil will intensify, and the complexity, severity and uncertainty of the external environment will rise.
In the macro environment of weak domestic infrastructure investment and weak recovery of consumption, the price spread and profitability of chemical products have not improved significantly, and the overall profitability of the chemical industry is still poor. According to the National Bureau of Statistics, the mainland's chemical sector will achieve a profit of 486.26 billion yuan in 2023, a year-on-year decrease of 31.2%.
The annual report shows that the total remuneration of directors, supervisors and senior managers of Zhengdan shares in 2023 is 5.3213 million yuan. Cao Zhengguo, chairman and general manager, received a total pre-tax remuneration of 1.2807 million yuan from the company, Cao Guiyun, the financial director, received a total pre-tax remuneration of 99,000 yuan from the company, and Cao Cuiqiong, director, deputy general manager and secretary of the board of directors, received a total pre-tax remuneration of 935,000 yuan from the company.
Zhengdan Co., Ltd. said in the recent investor survey that the company will continue to focus on the main business, accelerate the release of trimellitic anhydride, T0TM and tetraxylene production capacity, continue to expand the scale of operation, and use the company's core technology to further strengthen and expand in the advantageous market segments such as trimellitic anhydride and T0TM.